Cigalah Biopharma

Cigalah Biopharma is a prominent pharmaceutical and healthcare company based in Jeddah, Saudi Arabia, operating as a key division of the Cigalah Group. The company serves as a major distributor and manufacturer, providing a vital link between global pharmaceutical innovators and the Middle Eastern healthcare market. Its core business includes the marketing, sales, and logistics of a wide range of products, including prescription medicines, medical equipment, and consumer healthcare brands. Cigalah Biopharma operates sophisticated manufacturing facilities that produce localized versions of global brands, supporting Saudi Arabia's Vision 2030 initiative for pharmaceutical self-sufficiency. The company maintains long-standing strategic partnerships with international industry leaders such as Merck, Pfizer, and Novartis to ensure high-quality healthcare access throughout the region.